These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16105908)

  • 1. Extremely high titer of anti-human chimeric antibody following re-treatment with rituximab in a patient with active systemic lupus erythematosus.
    Saito K; Nawata M; Iwata S; Tokunaga M; Tanaka Y
    Rheumatology (Oxford); 2005 Nov; 44(11):1462-4. PubMed ID: 16105908
    [No Abstract]   [Full Text] [Related]  

  • 2. Humanized anti-CD20 monoclonal antibody in the treatment of severe resistant systemic lupus erythematosus in a patient with antibodies against rituximab.
    Tahir H; Rohrer J; Bhatia A; Wegener WA; Isenberg DA
    Rheumatology (Oxford); 2005 Apr; 44(4):561-2. PubMed ID: 15644390
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.
    Lee JW; Kim HA; Sung JM; Suh CH
    Lupus; 2010 Feb; 19(2):227-8. PubMed ID: 19884220
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus.
    ten Cate R; Smiers FJ; Bredius RG; Lankester AC; van Suijlekom-Smit LW; Huizinga TW; Egeler RM
    Rheumatology (Oxford); 2004 Feb; 43(2):244. PubMed ID: 14739467
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
    Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
    Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-CD20 therapy in systemic lupus erythematosus: a step closer to the clinic.
    Silverman GJ
    Arthritis Rheum; 2005 Feb; 52(2):371-7. PubMed ID: 15692969
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Fukushima T; Dong L; Sakai T; Sawaki T; Miki M; Tanaka M; Masaki Y; Hirose Y; Kuwana M; Umehara H
    Lupus; 2008 Mar; 17(3):210-4. PubMed ID: 18372362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
    Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA
    Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
    Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R
    Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
    Faria RM; Isenberg DA
    Lupus; 2010 Sep; 19(10):1256-7. PubMed ID: 20534646
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab: a promising therapy in systemic lupus erythematosus.
    Thatayatikom A; White AJ
    Autoimmun Rev; 2006 Jan; 5(1):18-24. PubMed ID: 16338207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20.
    Hong K; Presta LG; Lu Y; Penn A; Adams C; Chuntharapai A; Yang J; Wong WL; Meng YG
    J Immunol Methods; 2004 Nov; 294(1-2):189-97. PubMed ID: 15604027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG; Jones RB; Burns SM; Jayne DR
    Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
    Sutter JA; Kwan-Morley J; Dunham J; Du YZ; Kamoun M; Albert D; Eisenberg RA; Luning Prak ET
    Clin Immunol; 2008 Mar; 126(3):282-90. PubMed ID: 18226586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report.
    Hennigan S; Channick RN; Silverman GJ
    Lupus; 2008 Aug; 17(8):754-6. PubMed ID: 18625655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.
    Abdwani R; Mani R
    Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a peptide ELISA for the detection of rituximab in serum.
    Blasco H; Lalmanach G; Godat E; Maurel MC; Canepa S; Belghazi M; Paintaud G; Degenne D; Chatelut E; Cartron G; Le Guellec C
    J Immunol Methods; 2007 Aug; 325(1-2):127-39. PubMed ID: 17651747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and expression of chimeric anti-human CD20 monoclonal antibody].
    Wang YG; Huang Y; Gu X; Yu M; Feng JN; Sun YX; Li Y; Shen BF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):363-7. PubMed ID: 16643801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.